axitinib,epcoritamab
abbvie,genmab,pfizer
['epcoritamab', 'axi/', 'dlbcl']
great presentation of subcutaneous epcoritamab + r-dhax/c in patients with r/r dlbcl eligible for autologous sct: orr 85% cmr 65% #ash22 
Hematologist Hematology and Oncology Institute Donostia